Related Experiment Video
Updated: May 14, 2026

Intracerebroventricular Treatment with Resiniferatoxin and Pain Tests in Mice
Published on: September 2, 2020
Opioid withdrawal increases transient receptor potential vanilloid 1 activity in a protein kinase A-dependent manner
Viola Spahn1, Oliver Fischer, Jeannette Endres-Becker
1Charité - Universitätsmedizin Berlin, Klinik für Anaesthesiologie und operative Intensivmedizin, Campus Benjamin Franklin, Hindenburgdamm 30, Berlin 12203, Germany Universitätsklinikum Hamburg - Eppendorf, Klinik für Anästhesiologie, Hamburg 20251, Germany.
Abstract:
Hyperalgesia is a cardinal symptom of opioid withdrawal. The transient receptor potential vanilloid 1 (TRPV1) is a ligand-gated ion channel expressed on sensory neurons responding to noxious heat, protons, and chemical stimuli such as capsaicin. TRPV1 can be inhibited via μ-opioid receptor (MOR)-mediated reduced activity of adenylyl cyclases (ACs) and decreased cyclic adenosine monophosphate (cAMP) levels. In contrast, opioid withdrawal following chronic activation of MOR uncovers AC superactivation and subsequent increases in cAMP and protein kinase A (PKA) activity. Here we investigated (1) whether an increase in cAMP during opioid withdrawal increases the activity of TRPV1 and (2) how opioid withdrawal modulates capsaicin-induced nocifensive behavior in rats. We applied whole-cell patch clamp, microfluorimetry, cAMP assays, radioligand binding, site-directed mutagenesis, and behavioral experiments. Opioid withdrawal significantly increased cAMP levels and capsaicin-induced TRPV1 activity in both transfected human embryonic kidney 293 cells and dissociated dorsal root ganglion (DRG) neurons. Inhibition of AC and PKA, as well as mutations of the PKA phosphorylation sites threonine 144 and serine 774, prevented the enhanced TRPV1 activity. Finally, capsaicin-induced nocifensive behavior was increased during opioid withdrawal in vivo. In summary, our results demonstrate an increased activity of TRPV1 in DRG neurons as a new mechanism contributing to opioid withdrawal-induced hyperalgesia.
More Related Videos
09:39Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
12:20Use of the Operant Orofacial Pain Assessment Device (OPAD) to Measure Changes in Nociceptive Behavior
Published on: June 10, 2013
Related Concept Videos
Opioid Receptors: Overview
Analgesia and Pain Management
Desensitization and Tachyphylaxis
Several...
Opioid Analgesics: Synthetic and Semisynthetic Opioids
GPCR Desensitization
Opioid Analgesics: Morphine and Other Natural Cogeners